FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808403453> ?p ?o ?g. }

• W2808403453 endingPage "S8" @default.
• W2808403453 startingPage "S8" @default.
• W2808403453 abstract "PURPOSE: In vitro, the amino acid leucine has been able to reduce proteolysis and be a potent stimulus for protein synthesis. The purpose of this study was to determine the effect of leucine supplementation on indices of muscle damage and muscular function following eccentric-based resistance exercise. METHODS: Twenty-seven untrained individuals (Height: 178.62 ± 5.54 cm; Mass: 77.71 ± 13.46 kg) were randomly divided into 3 groups; leucine, placebo and control. The leucine and placebo groups performed 100 depth jumps from 60 cm and 6 sets of 10 repetitions of eccentric-only leg presses. Either leucine (250 mg/kg bm) or placebo was ingested at 3 time points during exercise and each recovery day following exercise. Each group's level of muscle damage was determined via serum levels of creatine kinase and myoglobin at pre-exercise (PRE) and 24, 48, 72 and 96 hours post-exercise. Creatine kinase was assessed using basic spectophotometric techniques and myoglobin was assessed using an ELISA. Muscle function was determined by peak force (PF) during an isometric squat and jump height (JH) and peak concentric force (PCF) during both a static jump (SJ) and countermovement jump (CMJ) at PRE and 24h, 48h, 72h and 96h post-exercise. Data was analyzed using a general linear model with repeated measures and Bonferroni post hoc tests. RESULTS: Creatine kinase was significantly elevated from PRE (354.8 ± 317.5 U/L) for the leucine group at 24h (713.4 ± 473.0 U/L) and significantly elevated from PRE (185.9 ± 117.7 U/L) for the placebo group at 72h (501.7 ± 434.3 U/L) and 96h (455.6 ± 326.0 U/L). Myoglobin was significantly elevated from PRE (24.03 ± 15.4 ng/ml) for the placebo group at 24h (66.3 ± 59.6 ng/ml) and 96h (52.9 ± 41.3 ng/ml). PF for the isometric squat significantly decreased across all time points for placebo group and 24h, 48h, and 72h for the leucine group. SJ JH significantly decreased from PRE (0.42 ± 0.05 m) for the placebo group at 24h (0.38 ± 0.04 m), 48h (0.38 ± 0.06 m) and 72h (0.39 ± 0.04 m). CMJ JH significantly decreased from PRE (0.46 ± 0.03 m) for the leucine group at 48h (0.42 ± 0.04 m), 72h (0.43 ± 0.03 m) and 96h (0.39 ± 0.14 m) and also from PRE (0.48 ± 0.05 m) for the placebo group at 24h (0.44 ± 0.08 m), 48h (0.43 ± 0.07 m) and 72h (0.43 ± 0.06 m). SJ PCF significantly increased from PRE (1652.1 ± 226.0 N) for the leucine group at 48h (1728.9 ± 264.8 N), 72h (1725.8 ± 279.5 N) and 96h (1730.0 ± 270.0 N) and was significantly higher compared to the placebo group at 24h and 48h. CMJ PCF significantly increased from PRE (1673.6 ± 308.7 N) for the placebo group at 48h (1760.6 ± 399.5 N). CONCLUSIONS: Leucine supplementation does not appear to be a viable choice for reducing immediate muscle damage following eccentric exercise; however leucine may facilitate the recovery process. Leucine may need further examination, as it was unable to shown a between group difference compared to placebo but did minimize the change in muscle damage markers compared to PRE. Leucine supplementation did not attenuate the initial decrement in PF during an isometric squat but did return PF back to baseline by the 96 hour time point. For contractions that are not accompanied by a stretch-shorten cycle, leucine supplementation minimized the decrement in muscle function and maintained PF output when compared to a placebo. Practical Applications: Supplementing with leucine by itself may not completely reduce the levels of muscle damage that follow high-intensity resistance training, but may help maintain force generating capabilities. Therefore, increasing leucine consumption, in concurrence with other nutritional recovery protocols, may help maintain muscle function during contractions that are not preceded by a stretch-shorten cycle." @default.
• W2808403453 created "2018-06-21" @default.
• W2808403453 creator A5016998402 @default.
• W2808403453 creator A5018528993 @default.
• W2808403453 creator A5043079343 @default.
• W2808403453 creator A5044816802 @default.
• W2808403453 creator A5047559176 @default.
• W2808403453 creator A5074111889 @default.
• W2808403453 date "2011-03-01" @default.
• W2808403453 modified "2023-09-25" @default.
• W2808403453 title "The Effect of Leucine Supplementation on Muscle Damage and Muscular Function Following Eccentric Exercise" @default.
• W2808403453 doi "https://doi.org/10.1097/01.jsc.0000395591.09865.6d" @default.
• W2808403453 hasPublicationYear "2011" @default.
• W2808403453 type Work @default.
• W2808403453 sameAs 2808403453 @default.
• W2808403453 citedByCount "0" @default.
• W2808403453 crossrefType "journal-article" @default.
• W2808403453 hasAuthorship W2808403453A5016998402 @default.
• W2808403453 hasAuthorship W2808403453A5018528993 @default.
• W2808403453 hasAuthorship W2808403453A5043079343 @default.
• W2808403453 hasAuthorship W2808403453A5044816802 @default.
• W2808403453 hasAuthorship W2808403453A5047559176 @default.
• W2808403453 hasAuthorship W2808403453A5074111889 @default.
• W2808403453 hasConcept C100784341 @default.
• W2808403453 hasConcept C103486182 @default.
• W2808403453 hasConcept C121332964 @default.
• W2808403453 hasConcept C126322002 @default.
• W2808403453 hasConcept C134018914 @default.
• W2808403453 hasConcept C142724271 @default.
• W2808403453 hasConcept C185592680 @default.
• W2808403453 hasConcept C1862650 @default.
• W2808403453 hasConcept C204787440 @default.
• W2808403453 hasConcept C2524010 @default.
• W2808403453 hasConcept C27081682 @default.
• W2808403453 hasConcept C2776580952 @default.
• W2808403453 hasConcept C2778063876 @default.
• W2808403453 hasConcept C2778820510 @default.
• W2808403453 hasConcept C2779896295 @default.
• W2808403453 hasConcept C33923547 @default.
• W2808403453 hasConcept C36880943 @default.
• W2808403453 hasConcept C515207424 @default.
• W2808403453 hasConcept C55493867 @default.
• W2808403453 hasConcept C62520636 @default.
• W2808403453 hasConcept C71924100 @default.
• W2808403453 hasConcept C90296322 @default.
• W2808403453 hasConceptScore W2808403453C100784341 @default.
• W2808403453 hasConceptScore W2808403453C103486182 @default.
• W2808403453 hasConceptScore W2808403453C121332964 @default.
• W2808403453 hasConceptScore W2808403453C126322002 @default.
• W2808403453 hasConceptScore W2808403453C134018914 @default.
• W2808403453 hasConceptScore W2808403453C142724271 @default.
• W2808403453 hasConceptScore W2808403453C185592680 @default.
• W2808403453 hasConceptScore W2808403453C1862650 @default.
• W2808403453 hasConceptScore W2808403453C204787440 @default.
• W2808403453 hasConceptScore W2808403453C2524010 @default.
• W2808403453 hasConceptScore W2808403453C27081682 @default.
• W2808403453 hasConceptScore W2808403453C2776580952 @default.
• W2808403453 hasConceptScore W2808403453C2778063876 @default.
• W2808403453 hasConceptScore W2808403453C2778820510 @default.
• W2808403453 hasConceptScore W2808403453C2779896295 @default.
• W2808403453 hasConceptScore W2808403453C33923547 @default.
• W2808403453 hasConceptScore W2808403453C36880943 @default.
• W2808403453 hasConceptScore W2808403453C515207424 @default.
• W2808403453 hasConceptScore W2808403453C55493867 @default.
• W2808403453 hasConceptScore W2808403453C62520636 @default.
• W2808403453 hasConceptScore W2808403453C71924100 @default.
• W2808403453 hasConceptScore W2808403453C90296322 @default.
• W2808403453 hasLocation W28084034531 @default.
• W2808403453 hasOpenAccess W2808403453 @default.
• W2808403453 hasPrimaryLocation W28084034531 @default.
• W2808403453 hasRelatedWork W1792003353 @default.
• W2808403453 hasRelatedWork W2003448110 @default.
• W2808403453 hasRelatedWork W2006575662 @default.
• W2808403453 hasRelatedWork W2018782916 @default.
• W2808403453 hasRelatedWork W2041192322 @default.
• W2808403453 hasRelatedWork W2058593102 @default.
• W2808403453 hasRelatedWork W2072231362 @default.
• W2808403453 hasRelatedWork W2468861618 @default.
• W2808403453 hasRelatedWork W2586665302 @default.
• W2808403453 hasRelatedWork W4206939158 @default.
• W2808403453 hasVolume "25" @default.
• W2808403453 isParatext "false" @default.
• W2808403453 isRetracted "false" @default.
• W2808403453 magId "2808403453" @default.
• W2808403453 workType "article" @default.